Radboud university Nijmegen Medical Centre
Nijmegen, Gelderland, 6533 ZA, Netherlands
NCT Number: NCT00268554
The purpose of this study is to determine whether dipyridamole enhances postocclusive reactive hyperaemia by increasing extracellular adenosine concentrations during ischemia and reperfusion. Furthermore we hypothesize that dipyridamole augments postocclusive reactive hyperaemia by increasing adenosine receptor stimulation.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Nijmegen, Gelderland, 6533 ZA, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Radboud University Medical Center
Other
Enhancement of Postocclusive Reactive Hyperaemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05706181
Aging Well, Body Temperature Changes
Fort Worth, Texas, United States
View Trial DetailsNCT01959243
Cardiovascular Diseases, Hyperemia
Phoenix, Arizona, United States
View Trial DetailsNCT01959230
Cardiovascular Diseases, Hyperemia
Memphis, Tennessee, United States
View Trial DetailsNCT02039765
Cardiovascular Diseases, Hyperemia
Rochester, New York, United States
View Trial Details